dihydrolipoic acid has been researched along with Malignant Melanoma in 1 studies
dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Micillo, R | 1 |
| Sirés-Campos, J | 1 |
| García-Borrón, JC | 1 |
| Panzella, L | 1 |
| Napolitano, A | 1 |
| Olivares, C | 1 |
1 other study available for dihydrolipoic acid and Malignant Melanoma
| Article | Year |
|---|---|
Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase.
Topics: Agaricales; Caffeic Acids; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme | 2018 |